ArticleOncoTargets and therapy2021

Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer.

Yichao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.